News

Your day-ahead look for Feb. 14, 2025

Biotechnology company Moderna (NASDAQ:MRNA) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other hand, the company’s full-year revenue guidance of $2 billion at the midpoint came in 9.8% below analysts’ estimates. Its GAAP loss of $2.91 per share was 6.7% below analysts’ consensus estimates.

Japan Tobacco International expects a shift towards cheaper cigarette brands in the United States to reach more than 40% of the market by 2027, its finance chief told Reuters. U.S. smokers have been swapping out brands such as Altria's Marlboro and British American Tobacco's (BAT) Newport, which have been raising prices for years, for less expensive brands as high inflation and interest rates stretch their wallets. BAT's U.S. cigarette volumes fell 10.1% last year in part due to this shift, it reported on Thursday, while Altria has also been losing market share.

Coinbase touts a pro-crypto market backdrop for a big quarter.

Egg prices are both universal and easy to dismiss, as they're not used in "core" inflation. But they're important, almost psychologically, for consumers and the Fed.

War-torn countries, those with high levels of debt and U.S. allies such as Jordan have the most to lose if the United States Agency for International Development is dismantled, as proposed by the Trump administration. USAID has provided significant budgetary support in Ukraine and Jordan in particular, JPMorgan noted, and making up the lost support for healthcare, agriculture and infrastructure in those countries and elsewhere will be tough. JPMorgan said a permanent loss of USAID money was not enough to destabilise the economy in any of the roughly 30 emerging markets it tracks closely.

President Trump’s domestic AI focus is a good sign for Intel, but easy fixes have proven elusive.